Skip to content

Clinical trials

Observational Ventilator-Induced Lung Injury trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ventilator-Induced Lung Injury Phase: Observational Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20121
20131
20161
20172
20184
20194
20206
20212
20223
20235
20246
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting9
Unknown status5
Not yet recruiting5
Active, not recruiting3
Withdrawn2
Terminated1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Başakşehir Çam & Sakura City Hospital3
Assistance Publique - Hôpitaux de Paris2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2
Hospital El Cruce2
Unity Health Toronto2
Assiut University1
Ayse Ulgey1
Bakirkoy Dr. Sadi Konuk Research and Training Hospital1
Canadian Critical Care Trials Group1
Centre Hospitalier de Saint-Brieuc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ventilator-Induced Lung Injury43
Respiratory Distress Syndrome13
Respiratory Insufficiency5
Lung Injury3
Critical Illness2
Lung Diseases2
Pneumonia2
Pneumonia, Ventilator-Associated2
Pulmonary Atelectasis2
Acute Lung Injury1

Trials

Showing 76 to 43 of 43. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.